Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

MASH faced an issue that almost no other sitcom has been able to overcome, but this ended up somehow making the classic ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...